Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641489-25-000022
Filing Date
2025-04-24
Accepted
2025-04-24 16:40:29
Documents
4
Period of Report
2024-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1745527221.html 4  
1 FORM 4 wk-form4_1745527221.xml 4 6023
2 EX-24 powerofattorney-secfilin.htm EX-24 4157
3 GRAPHIC powerofattorney-secfilin001.jpg GRAPHIC 235204
4 GRAPHIC powerofattorney-secfilin002.jpg GRAPHIC 41614
  Complete submission text file 0001641489-25-000022.txt   393165
Mailing Address 565 EVERETT AVENUE PALO ALTO CA 94301
Business Address
AKKARAJU SRINIVAS (Reporting) CIK: 0001253170 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37524 | Film No.: 25868216

Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Issuer) CIK: 0001641489 (see all company filings)

EIN.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)